Yongqian Shu

6PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical mycologyMolecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 15, 2021
Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double-blind randomized phase 2 trial.

Jing Huang, Juxiang Xiao, Wentao Fang

|Jul 01, 2020
Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation.

Mengyan Xie, Tao Yu, Xinming Jing

|Nov 16, 2019
The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis.

Chuchu Shao, Fengming Yang, Zhiqiang Qin

|Nov 13, 2019
Role of hypoxia in cancer therapy by regulating the tumor microenvironment.

Xinming Jing, Fengming Yang, Chuchu Shao

|Jun 26, 2019
miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer.

Fengming Yang, Chuchu Shao, Ke Wei

|Jul 18, 2018
Association between VEGF Gene Polymorphisms and the Susceptibility to Lung Cancer: An Updated Meta-Analysis.

Fengming Yang, Zhiqiang Qin, Chuchu Shao

Pageof 1

Frequent Collaborators

1 joint publications

Hua Shen

1 joint publications

Jing Huang